AIDS and the urologist

Urologic Clinics of North America

Volumn 30, Issue 1, 2003, Pages 101-109

  Hyun, Grace ^a   Lowe, Franklin C ^a,b  

^a College of Physicians and Surgeons ^*  (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; FLUOROURACIL; INDINAVIR; NELFINAVIR; RETINOID; RITONAVIR; SAQUINAVIR; SILDENAFIL; THALIDOMIDE; VASCULOTROPIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL FEATURE; DISEASE COURSE; ERECTILE DYSFUNCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; KAPOSI SARCOMA; KIDNEY CARCINOMA; LYMPHOMA; MICTURITION DISORDER; NEPHROLITHIASIS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROSTATITIS; REVIEW; SQUAMOUS CELL CARCINOMA; TESTIS ATROPHY; TESTIS TUMOR;

ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; FEMALE UROGENITAL DISEASES; HUMANS; MALE; MALE UROGENITAL DISEASES;

EID: 0037310278     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(02)00124-6     Document Type: Review

References (82)

1. Chiasson. NYC AIDS case mortality rates in the era of potent antiretroviral therapy. J Urban Health 2000;77:255-7.
2. Heylen R, Miller R. Adverse effects and drug interactions of medications commonly used in the treatment of adult HIV-positive patients: part 2. Genitourin Med 1997;73:5-11.
3. Tashima KT, Horowitz JD, Rosen S. Indinavir nephropathy. N Engl J Med 1997;336:138-9.
4. Bruce RG, Munch LC, Hoven AD, et al. Urolithiasis associated with the protease inhibitor indinavir. Urology 1997;50:513-8.
5. Daudon M, Estepa L, Viard JP, et al. Urinary stones in HIV-1 positive patients treated with indinavir. Lancet 1997;349:1294-5.
6. Steele BW, Carson CC. Recognizing the urologic manifestations of HIV and AIDS. Contemp Urol 1997;9:39-53.
7. Crixivan. (indinavir sulfate)-US package insert. West Point, (PA): Merck and Co.; 1996.
8. Kopp JB, Miller KD, Mican JM, et al. Crystalluria and urinary tract abnormalities associated with indinavir. Ann Intern Med 1997;127:119-25.
9. Engeler DS, John H, Rentsch KM, et al. Nelfinavir urinary stones. J Urol 2002;167:1384-5.
10. Morant J, Ruppanner H. The Swiss Drug Compendium 2001, 22nd edition. Basel (Switzerland): Documed, AG, 2000; p. 2721-2.
11. Hug B, Naef M, Bucher HC, et al. Treatment for human immunodeficiency virus with indinavir may cause relevant urological side-effects, effectively treatable by rehydration. BJU Int 1999;84(6):610-4.
12. Sutherland SE, Reigle MD, Seftel AD, et al. Protease inhibitors and urolithiasis. J Urol 1997;158:31-3.
13. Gyrtrup HJ, Kristiansen VB, Zachariae CO, et al. Voiding problems in patients with HIV infection and AIDS. Scand J Urol Nephrol 1995;29:295-8.
14. Menendez V, Espuna M, Perez A, et al. Neurogenic bladder in patients with acquired immuno-deficiency syndrome. Neurourol Urodyn 1995;14:253-7.
15. Hermieu JF, Delma V, Boccon-Gibod L. Micturition disturbances and human immunodeficiency virus infection. J Urol 1996;156:157-9.
16. Catanese AJ, Tessler AN, Morales P. AIDS and the urologist part I: urologic manifestation of AIDS (lesson 1). AUA Update Series 1989;8:1-8.
17. Kahn Z, Singh VK. Neurogenic bladder in acquired immune deficiency syndrome [abstract]. J Urol 1988;139:166A.
18. Kwan DJ, Lowe FC. Acquired immunodeficiency syndrome, a venereal disease. Urol Clin North Am 1992;19:13-24.
19. Dobs AS, Dempsey MA, Landenson PW, et al. Endocrine disorders in men infected with human immunodeficiency virus. Am J Med 1988;84:611-4.
20. Tindall B, Forde S, Goldstein D, et al. Sexual dysfunction in advanced HIV disease. AIDS Care 1994;6:105-7.
21. Levy JA. The transmission of HIV and factors influencing progression to AIDS. Am J Med 1993;95:86-100.
22. Kwan DJ, Lowe FC. AIDS and the urologist. Part I (lesson 37). AUA Update Series 1995;14:297-304.
23. Muirhead GJ, Wulff MB, Fielding A. Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir. Br J Clin Pharmacol 2000;50:99-107.
24. Leibovitch I, Goldwasser B. The spectrum of acquired immunodeficiency syndrome-associated testicular disorders. Urology 1994;44:818-24.
25. Pudney J, Anderson D. Orchitis and human immunodeficiency virus type I infected cells in reproductive tissues from men with the acquired immune deficiency syndrome. Am J Pathol 1991;139:149-60.
26. DePaepe ME, Waxman M. Testicular atrophy in AIDS: a study of 57 autopsy cases. Human Pathol 1989;20:210-4.
27. DePaepe ME, Guerrieri C, Waxman M. Opportunistic infections of the testis in the acquired immunodeficiency syndrome. Mt Sinai J Med 1990;57:25-9.
28. Vapneck JM. Urologic disease in HIV infection. AIDS Read 1991;1:64-72.
29. Adjiman S, Zerbib M, Flam T, et al. Genitourinary tumors and HIV-1 infection. Eur Urol 1990;18:61-3.
30. Gilling-Smith C. Assisted reproduction in HIV-discordant couples. The AIDS Reader. October 2000;10(10):581-7.
31. Kennedy WA, Benson MC, Kaplan SA. Urologic manifestations of HIV infection: Renal and Urologic Aspects of HIV Infection. New York: Churchill Livingstone; 1995. p. 181-193.
32. Piedbois P, Frikha H, Martin L, et al. Radiotherapy in the management of epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 1994;30:1207-11.
33. Chang Y, Cesarman E, Pessin M, et al. Identification of herpesvirus-like DNA sequence in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
34. Foreman KE, Friborg J, Kong W, et al. Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma. N Engl J Med 1997;336:163-71.
35. De Jarlais DC, Marmor M, Thomas P, et al. Kaposi's sarcoma amongst four different AIDS risk groups. N Engl J Med 1984;310:1119.
36. Osmond DH, Buchbinder S, Cheng A, et al. Prevalence of Kaposi Sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic. JAMA 2002;287(2):221-5.
37. Mitsuyasu RT. AIDS-related Kaposi's sarcoma: treatment options, future trends. Oncology 2000;14:867-78.
38. Pollok RCG, Francis N, Cliff S, et al. Kaposi's sarcoma in the kidney. Int J STD AIDS 1995;6:289-90.
39. Swierzewski III SJ, Wan J, Boffini A, et al. The management of meatal obstruction due to Kaposi's sarcoma of the glans penis. J Urol 1993;150:193-5.
40. Klein LT, Lowe FC. Penile gangrene associated with extensive Kaposi's sarcoma in patients with the acquired immunodeficiency syndrome. Urology 1995;46:425-8.
41. Lowe FC, Lattimer GD, Metroka CE. Kaposi's sarcoma of the penis in patients with acquired immunodeficiency syndrome. J Urol 1986;136:673-5.
42. Kwan DJ, Lowe FC. Acquired immunodeficiency syndrome in urology. part II: genitourinary manifestations of AIDS (lesson 38). AUA Update Series 1995;14:313-20.
43. Nisce LZ, Safai B, Poussin-Rosillo H. Once weekly total and subtotal skin electron beam therapy for Kaposi's sarcoma. Cancer 1981;47(4):640-4.
44. Safai B, Schwartz JJ. Kaposi's sarcoma and the acquired immunodeficiency syndrome. In: Devita Jr VT, Hellman S, Rosenberg SA, editors. AIDS: etiology, diagnosis, treatment and prevention. 3rd edition. Philadelphia: JB Lippincott; 1992. p. 209-23.
45. Conant MA, Opp RM, Foretz D, et al. Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonavir. AIDS 1997;11:1300-1.
46. Wilson TW, Frenkel E, Vultch F, et al. Testicular tumors in men with human immunodeficiency virus. J Urol 1992;147:1038-40.
47. Moyle G, Hawkins DA, Gazzard BG. Seminoma and HIV infections. Int J STD AIDS 1991;2:293-4.
48. Kaplan MH, Susin M, Pahwa SG, et al. Neoplastic complications of HTLV-III infection: lymphomas and solid tumors. Am J Med 1987;82:389-96.
49. Wilkinson M, Carroll PR. Testicular carcinoma in patients positive and at risk for human immunodeficiency virus. J Urol 1990;144:1157-9.
50. Munver R, Donehower RC, Kronz JD, et al. HIV infection presenting as an unusually large pure yolk sac tumor of the testis. J Urol 2000;164:1653-4.
51. Monfardini S, Vaccher E, Pizzocaro G, et al. Unusual malignant tumors in 49 patients with HIV infection. AIDS 1989;3:449-52.
52. Leibovitch I, Baniel J, Rowland RG, et al. Malignant testicular neoplasms in immunosuppressed patients. J Urol 1996;155:1938-42.
53. Baynham SA, Katner HP, Cleveland KB. Increased prevalence of renal cell carcinoma with HIV infection. Aids Patient Care STDS 1997;11(3):161-5.
54. Schwartz JD, Prince D. Prostate cancer in HIV infection. AIDS 1996;10(7):797.
55. Mohler JL, Jarow JP, Marshall FF. Unusual urological presentations of acquired immune deficiency syndrome: large cell lymphoma. J Urol 1987;138:627-9.
56. Sokovich RS, Bormes TP. Acquired immunodeficiency syndrome presenting as testicular lymphoma. J Urol 1992;147:1110-1.
57. Armenakas NA, Schevchuk MM, Brodherson M, et al. AIDS presenting as primary testicular lymphoma. Urology 1992;40:162-4.
58. Wang CY, Brodland GD, Su WP. Skin cancers associated with acquired immunodeficiency syndrome. Mayo Clin Proc 1995;70:766-72.
59. Lee LK, Dinneen MD, Ahmad S. The urologist and the patient infected with human immunodeficiency virus or with acquired immunodeficiency syndrome. BJU Int 2001;88:500-10.
60. Gerber GS. Carcinoma in situ of the penis. J Urol 1994;151:829-33.
61. Harth Y, Hirshowitz B, Kaplan B. Modified topical photodynamic therapy of superficial skin tumor, utilizing aminolevulinic acid, penetration enhancers, red light and hyperthermia. Dermatol Surg 1998;24:723-6.
62. Miles BJ, Mesler M, Farah R, et al. The urological manifestations of the acquired immunodeficiency syndrome. J Urol 1989;142:771-3.
63. Kaplan MS, Wechsler M, Benson MC. Urologic manifestations of AIDS. Urology 1987;30:441-3.
64. De Pinho AM, Lopes GS, Ramos-Filho CF, et al. Urinary tract infections in men with AIDS. Genitourin Med 1994;70:30-4.
65. Hoepelman AI, Van Buren M, Van den Broek J, et al. Bacteriuria in men infected with HIV-1 is related to their immune status (CD4+ cell count). AIDS 1992;6:179-84.
66. Evans JK, McOwan A, Hilman RJ, et al. Incidence of symptomatic urinary tract infections in HIV seropositive patients and the use of cotrimazole as prophylaxis against pneumocystis carinii pneumonia. Genitourin Med 1995;71:120-2.
67. Weinberger M, Cytron S, Servadio C, et al. Prostatic abscess in the antibiotic era. Rev Infect Dis 1988;10:239-49.
68. Fair WR, Couch J, Wehner N. The purification and assay of the prostatic antibacterial factor (PAF). Biochem Med 1973;8:329-39.
69. Leport C, Rousseau F, Perronne C, et al. Bacterial prostatitis in patients infected with the human immunodeficiency virus. J Urol 1989;141:334-6.
70. Trapnell J, Roberts M. Prostatic abscess. Br J Surg 1970;57:565-9.
71. Benson PJ, Smith CS. Cytomegalovirus prostatitis. Urology 1992;40:165-7.
72. Larsen RA, Bozzette S, McCutchan JA, et al. Persistent cryptococcus neoformans infection of the prostate after successful treatment of meningitis. Ann Intern Med 1989;11:125-8.
73. Centers for Disease Control and Prevention: HIV/AIDS Surveillance Report 1994;6(1):5-14.
74. Trauzzi SJ, Kay CJ, Kaufman DG, et al. Management of prostatic abscess in patients with the human immunodeficiency virus syndrome. Infect in Urol 1995;8:86-90.
75. Staiman VS, Lowe FC. Prostatic disease in HIV-infected patients. AIDS Read 1995;5:165-71.
76. Kay CJ, Trauzzi SJ, Lowe FC. Imaging and management of prostatic abscess associated with the human immunodeficiency virus syndrome. Infect in Urol 1995;8:86-90.
77. Mamo GJ, Rivero MA, Jacobs SC. Cryptococcal prostatic abscess associated with the acquired immunodeficiency syndrome. J Urol 1992;148:889-90.
78. Tessler AN, Catanese A. AIDS and germ cell tumors of testis. Urology 1987;30:203-4.
79. Marans HY, Mandell W, Kislak JW, et al. Prostatic abscess due to histoplasma capsulatum in the acquired immunodeficiency syndrome. J Urol 1991;145:1275-6.
80. Zighelboim J, Goldfarb RA, Mody D, et al. Prostatic abscess due to histoplasma capsulatum in a patient with acquired immunodeficiency syndrome. J Urol 1992;147:166-8.
81. Adams JR, Mata JA, Culkin DJ, et al. Acquired immunodeficiency syndrome manifesting as a prostate nodule secondary to cryptococcal infection. Urology 1992;29:289-91.
82. Lief M, Sarfarazi F. Prostatic cryptococcus in acquired immune deficiency syndrome. Urology 1986;28:318-9.